AzTrials
AzTrials

OsteoarthritisMobMPATINCT03160287

Mobile Motivational Physical Activity Targeted Intervention

A study testing Motivaltional interviews and infrequent motivational text messages in people with Osteoarthritis, run by University of Washington at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

More than 50% of older persons with osteoarthritis (OA) experience disrupted sleep and insomnia symptoms of difficulty falling asleep, awakening during the night, and awakening too early and being unable to fall back to sleep. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Osteoarthritis
What is being tested?
Motivaltional interviews and infrequent motivational text messages
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
1 Jun 2017to 30 Sep 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • >65 years of age
  • Clinically diagnosed OA of hip or knee
  • Positive for sleep deficiency, defined as Insomnia Severity Index>=12
  • Low physical activity based on Rapid Assessment of Physical Activity <=2
  • Stable use of pain, sleep and/or mood regulating medications over the past month
  • Resides in Seattle metropolitan area

Who cannot join

  • Acute injury associated with hip or knee pain
  • Inability to stand up without assistance
  • Memory Impairment Screen for Telephone (MIS-T) score of <4, suggesting cognitive impairment
  • Severe hearing or visual impairment
  • An acute episode or change in the treatment of psychiatric problems within the past 3 months
  • Diagnosed sleep disorder (e.g., sleep disordered breathing; insomnia).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Washington

    Seattle, Washington, 98195

Other trials in United States

About this study

Official title: Mobile Motivational Physical Activity Targeted Intervention (MobMPATI) to Improve Sleep in Older Adults With Osteoarthritis

More than 50% of older persons with osteoarthritis (OA) experience disrupted sleep and insomnia symptoms of difficulty falling asleep, awakening during the night, and awakening too early and being unable to fall back to sleep. Because OA pain has been implicated in sleep problems and because physical exercise interventions have been found to improve pain and sleep quality, staying physically active during the daytime is likely advantageous in terms of improving sleep. Physical exercise interventions with a duration between 10 and 16 weeks have been shown to improve quality of sleep in older adults with self-reported disrupted sleep. Unfortunately, recent reports show that older adults with OA are mainly sedentary and few meet national guidelines for recommended amounts of daily physical activity. A self-management intervention that integrates use of mobile technology to prompt older adults to be physically active, provides ongoing monitoring of the amount of their physical activity and includes self-efficacy enhancements is a novel non-pharmacological intervention both for prevention and treatment of sleep deficiency in persons with OA.

The proposed study will involve delivery of automatic physical activity-focused text messages, a novel sleep self-management diary (SleepTight) and motivational interviewing in participants with OA of the hip or knee (most commonly affected joints). The purpose of this Project is to pilot test a new self-management program: MobMPATI, a multidimensional, tailored intervention for sleep deficiency in for older adults with OA. The specific aims are to:

Read more
  1. Test the acceptability of MobMPATI for older adults with OA and poor sleep quality as a manifestation of sleep deficiency.
  2. Test the feasibility of implementing MobMPATI for older adults with OA, as well as collecting electronic data from the sample.
  3. Explore pre/posttest changes in self-efficacy, motivation and sleep deficiency measures [total sleep time (TST) and sleep efficiency (SE)] with the MobMPATI intervention.

This study will provide feasibility/acceptability and preliminary data necessary for a larger clinical trial of MobMPATI intervention to encourage physical activity and reduce sedentary behavior in older adults with OA as a way of reducing sleep deficiency. Preliminary testing of the intervention will indicate what measures are more sensitive in promoting self-efficacy and motivation so that a smaller number of outcomes could be monitored to reduce participant burden. This study is the first step in this innovative program of research. The knowledge gained will provide data on the benefit of a potentially cost-effective intervention that could be implemented on a large scale to improve health of older adults with OA.

Conditions
Osteoarthritis
Being tested
Motivaltional interviews and infrequent motivational text messages
Keywords
mobile, sleep, physical activity, older adults
Medical subject headings
Osteoarthritis, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivaltional interviews and infrequent motivational text messagesBehavioural

    A self-management intervention will integrate use of mobile technology to prompt older adults to be physically active, provides ongoing monitoring of the amount of their physical activity and includes self-efficacy enhancements is a novel non-pharmacological intervention both for prevention and treatment of sleep deficiency in persons with OA

Study groups in NCT03160287
Study groupRoleWhat they receive
Motivational interview and text messagesExperimentalMultidimensional, tailored intervention for sleep deficiency in for older adults with OA
Receives: Behavioral: Motivaltional interviews and infrequent motivational text messages

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mixed Effect Model Inferential Estimates of Longitudinal Changes Across 3 Time Points (Baseline, Week 14, Week 19) in Insomnia Severity Index

    Insomnia Severity Index (ISS)

    Score range 0 to 28 at each time point, with higher scores indicating more severe insomnia symptoms

    A single value for change in ISS across three-time points was calculated using linear mixed effect modeling

    Measured: Assessed at Baseline, week 14, week 19; change from baseline throughout three time points reported

  2. Mixed Effect Model Inferential Estimates of Longitudinal Changes Across Three Time Points (Baseline, Week 14, Week 19) in Actigraphy Total Sleep Time (TST)

    Actigraphy Total Sleep Time (TST) in minutes was calculated using baseline, week 14, and week 19 data from a wrist-worn actigraph

    A single value for change in TST across three-time points was calculated using linear mixed effect modeling

    A negative change score indicates lower TST ( in min) over time

    Measured: Assessed at Baseline, week 14, week 19; change from baseline throughout three time points reported

Secondary outcomes (3)
  1. Mixed Effect Model Inferential Estimates of Longitudinal Changes Across Three Time-points (Baseline, Week 14, Week 19) in Self-Efficacy (SE) to Manage Chronic Disease Scale

    Self-Efficacy to Manage Chronic Disease Scale

    Score range 1 to 10, with higher scores indicating better efficacy.

    A single value for change in SE across three-time points was calculated using linear mixed effect modeling

    Positive change score indicates an improvement in self-efficacy over time

    Measured: Assessed at Baseline, week 14, week 19; change from baseline throughout three time points reported

  2. Mixed Effect Model Inferential Estimates of Longitudinal Changes Across Three Time-points (Baseline, Week 14, Week 19) in Pain Score

    Pain

    Score range 1 to 10, with higher scores indicating worse symptoms.

    A single value for change in pain across three-time points was calculated using linear mixed effect modeling

    Positive change score indicates worsening in pain over time

    Measured: Assessed at Baseline, week 14, week 19; change from baseline throughout three time points reported

  3. Mixed Effect Model Inferential Estimates of Longitudinal Changes Across Three Time-points (Baseline, Week 14, Week 19) in Objectively Measured Step Count

    Fitbit devices were used to measure weekly step count at baseline, and week 14, and week 19

    A single value for change in step count across three-time points was calculated using linear mixed effect modeling

    A positive change indicates increased step count over time

    Measured: Assessed at Baseline, week 14, week 19; change from baseline throughout three time points reported

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2017
  2. Study start1 Jun 2017
  3. Primary completion31 Aug 2018
  4. Study completion30 Sep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03160287
Sponsor's protocol ID
52062
Acronym
MobMPATI
Status last verified
Apr 2023
First submitted
20 Apr 2017
Last updated
25 Apr 2023
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Motivaltional interviews and infrequent motivational text messages in people with Osteoarthritis, run by University of Washington at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 21 May 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mixed Effect Model Inferential Estimates of Longitudinal Changes Across 3 Time Points (Baseline, Week 14, Week 19) in Insomnia Severity Index (time frame: Assessed at Baseline, week 14, week 19; change from baseline throughout three time points reported). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
MobMPATI Clinical Trial NCT03160287 | AzTrials